Biophan US research deal on electrostim lead safety
This article was originally published in Clinica
Executive Summary
Biophan Technologies has formed a research partnership with the US FDA to help develop guidelines and standards for assessing the safety of cardiac pacemaker and neurostimulation leads when patients undergo magnetic resonance imaging (MRI).